DRAP reduces price of COVID-19 drug by Rs 1, 629
ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has reduced d the price of remdesivir, the first and only approved treatment for Covid-19 in the United States, by Rs1,629 taking the price down to Rs 9,244. According to a notification
DRAP permits clinical trials of plasma therapy for COVID-19 treatment
ISLAMABAD: Special Assistant to the Prime Minister on National Health Services Dr Zafar Mirza has said Drug Regulatory Authority of Pakistan (DRAP) has permitted clinical trials of plasma therapy for coronavirus treatment. In a statement, the health adviser said the
Countrywide crackdown launched against black-marketing of masks
ISLAMABAD: Drug Regulatory Authority of Pakistan (DRAP) has launched countrywide crackdown against black-marketing of respiratory masks and protection items for coronavirus. According to a spokesperson of Health Ministry, DRAP has raided several pharmacies in different countries over sale of protection
DRAP allows 7% increase in medicines’ prices
KARACHI: The Drug Regulatory Authority of Pakistan (DRAP) has allowed a seven percent increase in the prices of medicines per year. The drug manufacturing companies have increased by seven percent as per the notification issued by the DRAP. Common medications